Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 5/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.40 |
| ▸ | CTSV | O60911 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | CMA1 | P23946 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8188346 | 1.00 | DPP4 (0.40) | DPP4DPP8DPP9CTSVCTSL | |
| SCHEMBL7724507 | 1.00 | DPP4 (0.40) | DPP4DPP8DPP9CTSVCTSL | |
| SCHEMBL12142684 | 1.00 | DPP4 (0.40) | DPP4DPP8DPP9CTSVCTSL | |
| SCHEMBL30705634 | 1.00 | DPP4 (0.40) | DPP4DPP8DPP9CTSVCTSL | |
| Hydrochloric Acid SCHEMBL25310545 | 0.99 | DPP4 (0.39) | DPP4DPP8DPP9CTSVCTSL | |
| Hydrochloric Acid SCHEMBL25310550 | 0.99 | DPP4 (0.39) | DPP4DPP8DPP9CTSVCTSL | |
| Trifluoroacetic Acid SCHEMBL30489482 | 0.93 | CTSV (0.37) | DPP4DPP8DPP9CTSVCTSL | |
| SCHEMBL30557102 | 0.91 | CTSV (0.37) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL30556788 | 0.90 | CTSV (0.36) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL25076129 | 0.88 | DPP4 (0.39) | DPP4DPP8DPP9CTSVCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4166539-A1 | NITRILE-CONTAINING COMPOUNDS FOR USE AS MEDICAMENTS | Pfizer Inc. (US) | 2023-04-19 | — | — | EP | disclosed |